Archive for December, 2016
18 public hospitals stop drug mark-up in Jiangmen
The pilot implementation plan of the price adjustment of medical services in public hospitals in Jiangmen came recently into effect. According to the implementation plan, the 15% of drug mark-up is cancelled in 18 public hospitals in Jiangmen, to realize the drug sale without added profit (excluding traditional Chinese medicine decoction pieces), i.e. the actual purchase price is the sale price. Except the adjustment of the drug price, the prices of more than 90 examination and therapy items and around 2145 inspection items are reduced by 5%-12%. At the same time, the prices of five kinds of medical services which reflect the technical service values are increased, including examination fee, nursing care fee, bed fee, operation fee and therapy fee. (Source: Guangzhou Daily)
江门市18所城市公立医院取消药品加成
来源：广州日报 2016-12-09
核心提示：《江门市城市公立医院医疗服务价格调整实施方案(试行)》近日正式实施。按照该实施方案，江门18所公立医院自此取消原不超过15%的药品加成率，实现药品零差率销售(中药饮片除外)，即以实际购进价作为销售价格。除了药品价格的调整，90多项大型医用设备检查治疗项目和约2145项的检验项目收费标准分别下调5%- 12%。与此同时，5类体现医务人员技术劳务价值的医疗服务价格有所提高，其中包括诊查费、护理费、床位费、手术费和治疗费。
Adjusting the price management mode of low-price drugs in Hunan
Hunan Development and Reform Commission recently published an announcement concerning drug prices. The announcement clarifies related policies about drug prices in Hunan medical institutions. According to the announcement, since the publication date of the announcement, sales without added profit should be implemented basing on the actual purchase price, when public medical institutions sell drugs (including secondary vaccine, excluding traditional Chinese medicine decoction pieces). For the sale of traditional Chinese medicine decoction pieces in public medical institutions, the added profit should not exceed 30 % on the basis of the cost price with tax (the wholesale price). The added profit of non-public medical institutions and social retail pharmacies can be formulated by institutions and pharmacies themselves. Drug prices should be shown to the public. (Source: Chinese Medicine News)
湖南调整低价药品价格管理方式
来源：中国医药报 2016-12-08
核心提示：湖南省发改委日前下发《关于进一步明确药品价格有关问题的通知》，对湖南省医疗机构药品价格有关政策进行了明确。根据通知内容，自通知发布之日起，公立医疗机构销售药品(含二类疫苗，中药饮片除外)，以实际购进价格为基础，实行零差率销售;公立医疗机构销售中药饮片，以含税出厂价格(批发价格)为基础，按顺加不超过30%的加价率制定销售价格。非公立医疗机构和社会零售药店药品加价率由医疗机构和药店自主制定，并向社会公示药品价格。
CFDA ferrets out Illegal ingredients – five pharmaceutical manufacturers stop the production
In the evening of 7th December, CFDA published the No.159 casual inspection announcement in 2016. In the national drug casual inspection, drugs in six batches from five manufacturers were ferreted out to contain abietic acid or Scarlet 808. The Food and Drug Administrations of Jilin, Qinghai and Tibet Autonomous Region have already taken the product control actions to seal up, distrain, stop selling and recall the ferreted drugs. Withal CFDA asked FDAs of Jilin, Qinghai and Tibet Autonomous Region to immediately instruct the manufacturers to stop related productions and investigate the reasons thoroughly. The production should not be recovered until the reasons are clear and the rectifications are done. (Source: Chinamsr)
CFDA查出非法添加物，5药企停产！
来源：中国医药联盟 2016-12-08
核心提示：12月7日晚间，国家食药总局发布2016年第159号抽检通告。在国家药品抽验中，标示为吉林永利药业股份有限公司等5家企业生产的6批次药品检出松香酸或808猩红。对上述药品，吉林省、青海省、西藏自治区食品药品监督管理局已采取了查封扣押、暂停销售使用、要求企业主动召回等产品控制措施。对此，国家食品药品监督管理总局要求吉林省、青海省、西藏自治区食品药品监督管理局立即责令上述企业暂停相关产品生产，彻查药品质量问题原因，查清原因并整改到位前不得恢复生产。